Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | VIRVir Biotechnology, Inc.FY2025 · Dec |
|---|---|
| Revenue | $68.56M |
| Revenue, yoy | −7.6% |
| Net income | $437.99M |
| Net income, yoy | +16.1% |
| Net margin | -638.9% |
| Free cash flow | $396.61M |
| FCF margin | -578.5% |
| EPS, diluted | $3.16 |
Add another company.